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Abstract
Background: Human Aortic Preferentially Expressed Protein-1 (APEG-1) is a novel specific
smooth muscle differentiation marker thought to play a role in the growth and differentiation of
arterial smooth muscle cells (SMCs).
Results: Good quality crystals that were suitable for X-ray crystallographic studies were obtained
following the truncation of the 14 N-terminal amino acids of APEG-1, a region predicted to be
disordered. The truncated protein (termed ∆APEG-1) consists of a single immunoglobulin (Ig) like
domain which includes an Arg-Gly-Asp (RGD) adhesion recognition motif. The RGD motif is
crucial for the interaction of extracellular proteins and plays a role in cell adhesion. The X-ray
structure of ∆APEG-1 was determined and was refined to sub-atomic resolution (0.96 Å). This is
the best resolution for an immunoglobulin domain structure so far. The structure adopts a Greek-
key β-sandwich fold and belongs to the I (intermediate) set of the immunoglobulin superfamily. The
residues lying between the β-sheets form a hydrophobic core. The RGD motif folds into a 310 helix
that is involved in the formation of a homodimer in the crystal which is mainly stabilized by salt
bridges. Analytical ultracentrifugation studies revealed a moderate dissociation constant of 20 µM
at physiological ionic strength, suggesting that APEG-1 dimerisation is only transient in the cell. The
binding constant is strongly dependent on ionic strength.
Conclusion: Our data suggests that the RGD motif might play a role not only in the adhesion of
extracellular proteins but also in intracellular protein-protein interactions. However, it remains to
be established whether the rather weak dimerisation of APEG-1 involving this motif is physiogically
relevant.
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Arterial smooth muscle cells (SMC) are essential for the
formation and function of the cardiovascular system.
Abnormalities in their growth can cause a wide range of
human disorders such as atherosclerosis, the principal
cause for heart failure, thus the leading cause for deaths in
the western world [1-3]. The molecular mechanisms that
regulate SMC growth and differentiation are unclear
partly due to the lack of specific markers and defined in
vitro differentiation systems [4]. The recently discovered
Aortic Preferentially Expressed Protein-1 (APEG-1) may
serve as a sensitive marker for vascular SMC differentia-
tion. APEG-1 is expressed in differentiated vascular SMC
in vivo and was found to be down-regulated rapidly in de-
differentiated vascular SMC in vitro and in injured arteries
in vivo [5,6].
Recently, three additional, larger products of the APEG-1
gene have been identified in rodents: in striated muscle,
SPEGα and SPEGβ, and in the brain, BPEG [7]. The origi-
nally discovered APEG-1 mRNA is transcribed from a dif-
ferent promoter than the SPEGβ mRNA. This promoter is
located between two exons of the much larger SPEGβ
open reading frame. SPEGβ contains a serine/threonine
kinase domain, and several immunoglobulin and
fibronectin structural domains. The immunoglobulin
sequences and the pattern of surrounding domains of
SPEG proteins have significant homology with the
smooth muscle myosin light chain kinase (smMLCK) and
the giant muscle protein titin. Therefore, it has been
hypothesized that all four protein products of the APEG-1
gene (APEG-1, BPEG, SPEGα and SPEGβ) are part of the
functionally and structurally diverse smMLCK protein
family [7].
The amino acid sequence of APEG-1 (SwissProt Q15772)
defines a single Ig-like domain (Figure 1A). Ig-like
domains adopt a Greek-key β-sandwich fold and contain
two β-sheets that pack against each other. In Ig-like
domains of the I-set, one sheet is composed of four β-
strands (ABED) and the other comprises five β-strands
(A'GFCC') [8]. A disulfide bond is formed between
strands B and F in most of the extracellular Ig domains
which is essential for their structural integrity [9] whereas
intracellular Ig domains are stabilized by a hydrophobic
core [10,11]. Biochemical studies suggest that APEG-1 is a
nuclear protein [5] despite the as yet unrecognized
nuclear localization signal [12]. Ig domains interact with
a wide variety of other proteins either by end-to-end con-
tacts of the loops from opposite ends of the β-sandwich or
by sheet-sheet contacts [13].
A PROSITE database [14] search revealed that APEG-1
contains an Arg-Gly-Asp (RGD) adhesion recognition
motif. The RGD motif is found in a number of proteins
that play a role in cell adhesion, including some forms of
collagens, fibrinogen, vitronectin, von Willebrand factor
(VWF), snake disintegrins and slime mold dicoidins
(PROSITE: PDOC00016). The RGD sequence is also
found in several important extracellular matrix proteins
and serves as an adhesion ligand for members of the
integrin family of cell-surface receptors [15-17]. Experi-
mentally determined structures of cell-adhesion proteins
reveal that the RGD motif is localized within loop regions
and can adopt a broad set of conformations [18].
The Protein Structure Factory [19] is developing novel
strategies to address targets of its Homo sapiens structural
genomics effort which initially failed to yield good quality
crystals. In this paper, we describe the success in crystalli-
zation of APEG-1 by truncation of an amino-terminal




Since the full-length APEG-1 could not be crystallized, a
novel strategy for protein production [21,22] was applied.
Structurally disordered regions of the protein were pre-
dicted with COILS, REMARK465 and HOT LOOPS from
the DisEMBL™ package [23] and with PONDR® [24]. The
program PONDR® predicted disorder at the N-terminus
up to amino acid 18 whereas COILS and REMARK465
predict a disordered stretch up to amino acid 23. How-
ever, due to the start of the Ig domain at residue 20 (Swiss-
Prot Q15772, Figure 1A) disorder is unlikely beyond this
point.
PONDR® predicted thirteen C-terminal residues to be dis-
ordered which is contradictory to the results obtained
with COILS which predicts order in this region. COILS has
been proposed to be effective as a filter to remove false
positive predictions made by other networks [23]. These
analyses show that it may be helpful to consider more
than one disorder prediction algorithm for correct assign-
ment. In the structure, the C-terminus was later found to
be ordered except for the very last amino acid.
The N-terminus was truncated by 14 residues, and the
truncated (∆APEG-1) protein was prepared which showed
monodispersity like the full-length protein. Similar ther-
mal stability was determined by differential scanning
calorimetry for both proteins; the midpoints of the
unfolding transition were 56.3°C and 54.4°C for ∆APEG-
1 and APEG-1, respectively.
Structure description and comparison
The truncation approach proved successful, and the crys-
tal structure of ∆APEG-1 was determined to a resolution
of 0.96 Å (Figure 1B).Page 2 of 8
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tures of immunoglobulin domains. The immunoglobulin
structure with the highest resolution as yet was found to
be PDB 1K5N (1.09 Å) [25].
The structure of APEG-1 shows the intermediate set (I set)
immunoglobulin superfamily fold [13] which consists of
a β-sandwich forming a central hydrophobic core. The
front sheet comprises strands A'GFCC' which are arranged
with A' and G parallel and GFCC' anti-parallel, whereas
the back sheet comprises strands ABED oriented anti-par-
allel to one another. In addition, one 310 helix containing
the RGD sequence lies near the C-terminus. The main
hydrophobic core of the domain is formed around the
aromatic residues W53, F22 and Y91 (Figure 2).
The structural topology of ∆APEG-1 closely resembles that
of the prototypical I set domains of the Ig fold superfamily
[26], such as those found in telokin (PDB 1FHG, 1TLK;
r.m.s.d = 0.9 Å; 33.3% sequence identity) [27] and the I1
domain of the striated muscle protein titin (PDB 1G1C;
r.m.s.d = 1.1 Å; 26% identity) [28] (Figure 1A). Telokin is
identical to the C-terminal domain of myosin light chain
kinase (MLCK) which is a key enzyme in the regulation of
contractile activity in smooth muscle. Both APEG-1 and
telokin are proteins that contain an Ig-like domain and
represent a small portion of a larger muscle kinase (SPEGβ
and MLCK, respectively) [7].
A disulfide linkage is normally present in extracellular
immunoglobulin domains between strands B and F. In
∆APEG-1 this is replaced by hydrophobic interactions
between residues I41 and C93 in strands B and F, respec-
tively (Figure 2). The other main hydrophobic residue
pairs anchored in the core are V51 (strand C) – C76
(strand E), C104 (strand G) – S25 and L26 (loop between
strands AA'), and M39 (strand B) – Y91 (strand F). The
superposition of the structures of telokin, the titin I1
domain and ∆APEG-1 reveals that the residues which
compose the hydrophobic core are highly conserved in
arrangement and packing volume.
Telokin contains four cysteines in the core which have the
potential to form two disulfide bonds. Three of these
cysteines are also present in ∆APEG-1 (Figure 1A). A
disulfide bridge is observed in the structure of the titin I1
domain which was described as the first disulfide bridge
found in an intracellular Ig domain [28]. This bridge con-
nects β-strands C and E (C37-C62) and thus the front and
back sheets of the I1 β-sandwich. Only one cysteine of this
bridge is present in ∆APEG-1 and no disulfide linkages
were found (Figure 2). The alternative side chain confor-
mation of C93 bears the potential to form a disulfide
bond with C104 which would link the adjacent strands F
and G of the front sheet of the β-sandwich. However,
modeling with Coot [29] resulted in an S-S distance of 2.6
Å, which is considerably longer than the normal disulfide
bond of 2.0–2.1 Å.
The residues forming the hydrogen bonds and salt bridges
at the interface region – E33, R55, R65 and D87 of the
RGD motif – are highly conserved in the three proteins.
Structure and sequence alignment of APEG-1Figure 1
Structure and sequence alignment of APEG-1. A: 
Alignment of APEG-1 with the I1 domain of titin (PDB 
1G1C) and the telokin domain of MLCK (PDB 1FHG). The 
β-strands are labeled according to Ig fold I set nomenclature. 
The N-terminal 14 residues and the adhesion recognition 
RGD motif are highlighted. B: Ribbon diagram of the 
∆APEG-1 monomer. The front sheet (strands A'GFCC') and 
back sheet (strands ABED), are colored purple and pink, 
respectively. The 310 helix is shown in orange.
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observed in the structure of the I1 domain or telokin.
Homophilic interaction
∆APEG-1 crystallized as a monomer in the asymmetric
unit and an accessible surface area (asa) of 5775 Å2 was
found for a single subunit. Each ∆APEG-1 molecule forms
three distinct inter-protein contacts with neighbors, bury-
ing surface areas of 11.2% (648 Å2), 7.8% (420 Å2) and
6.7% (387 Å2). These values are all within the range of
buried asa observed in protein dimer structures (6.5–
29.4%) [30]. The large contact regions suggest that
∆APEG-1 can form homophilic interactions. The
homodimer with the largest buried surface area utilizes
end-to-end packing with the subunits' N-termini pointing
in opposite directions (Figure 3A). The residues involved
in formation of this dimer are exclusively located within
the loop cluster between strands CC', C'D and EF which
lie close to the C-terminus and within the 310 helix which
contains the RGD motif. These loops are interconnected
by salt bridges and a number of hydrogen bonds. The
dimer interface includes two buried bi-dentate salt bridges
– involving the RGD motif – between R65-D87 and R65'-
D87' (the apostrophe denotes the adjacent ∆APEG-1 mol-
ecule). These buried salt bridges are further stabilized by
salt bridge interactions between E84-R65' and E84'-R65,
respectively, and the interactions between E33-R66' and
R66-E33'. Additionally, the dimer interface has several
van der Waals interactions and water-mediated hydrogen
bonds between residues R85, G86, R55, Q58 and the sym-
metry-related mates R85', G86', R55', Q58' which further
stabilize the dimer interface. The backbone oxygen atom
O of G86 is bonded to Nζ2 of R55, the last residue of
strand C, and the backbone amide of R85 to the oxygen
Oε2 of E33. A strong, but unfavorable, interaction between
E84-D63', E84'-D63 is also observed at the dimer inter-
face.
The quaternary structure was investigated by sedimenta-
tion equilibrium in an analytical ultracentrifuge. An aver-
age dimer dissociation constant of Kd = 20 µM derived
from the concentration-dependent Mw measurements was
obtained for both full-length APEG-1 and ∆APEG-1 at 100
mM NaCl, demonstrating the nearly identical amount of
dimers (Figure 3B). The dissociation constant was deter-
mined as a function of the salt concentration, and a pro-
nounced correlation was found, as expected for
interactions which are stabilized by salt bridges (Figure
3B, inset). The dissociation constant is increased hundred
fold – from 2 µM to 200 µM – when the salt concentration
is increased from 0 to 250 mM.
Discussion
Prediction and removal of disordered regions proved to
be a successful strategy for the crystallization and struc-
tural analysis of APEG-1. We assume that the flexible,
unstructured N-terminus was the reason for earlier fail-
ures to crystallize the full-length protein. The I set of Ig
proteins is characterized by a hydrophobic core that is
important for their stability and activity [11]. The exami-
nation of the hydrophobic cores of several I-set proteins
reveals that they are flexible and can tolerate considerable
variation of hydrophobic residues particularly on the
edges of the core [8,31]. The absolute invariants within
the core are tryptophan (W53) and tyrosine (Y91). A com-
parison of the structure with I-set domains of the muscle
proteins telokin and titin reveals that residues get shuffled
within the β-sheets causing local conformational changes
in the side chains while the closely packed hydrophobic
core is maintained. A disulfide bond links the two β-
sheets of the titin I1 domain. No disulfide linkage was
found in ∆APEG-1. A potential disulfide bond in ∆APEG-
1 would link adjacent strands of the front sheet of the β-
sandwich.
To our knowledge, the APEG-1 structure has the highest
resolution of all structures of Ig(-like) domains currently
present in the Protein Data Bank.
A comparison of the C-terminal loop clusters of ∆APEG-1
and the I1 domain of titin is of interest. Residues at the
interface and the hydrogen bonding network are con-
served between the two. The I1 domain of titin forms
homodimers in solution and in the crystalline state, but
these have a different arrangement from the APEG-1
Cross section of the hydrophobic coreFigure 2
Cross section of the hydrophobic core. Electron density 
map contoured at 3σ.Page 4 of 8
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evant [28].
The dimerisation of APEG-1 showed a very pronounced
salt-dependence, which implies that it is caused by Cou-
lomb interactions. This supports the conclusion that the
dimerisation observed with the sedimentation equilib-
rium technique involves the RGD motif and the salt
bridges in the end-to-end contacts of the crystal structure.
The dissociation constant of the APEG-1 dimer of 20 µM
at physiological ionic strength is quite high and implies
that APEG-1 dimerisation could only be transient at phys-
iological conditions.
APEG-1 appears not only as an isolated protein, but also
becomes part of the large protein kinase SPEGβ, an alter-
native product of the APEG-1 gene. The dimerisation of
the APEG-1 Ig-like domain could induce antiparallel
homodimerisation of SPEGβ. This dimerisation could be
stabilized by additional binding sites within the large
SPEGβ protein.
The RGD motif is crucial for a number of extracellular pro-
tein binding events and cellular adhesion [16-18]. The
structural flexibility of C-terminal loops with RGD motifs
in published adhesion molecule structures was suggested
to allow the molecules to adopt a broad range of confor-
mations in molecular adhesion events [18]. RGD motifs
in extracellular proteins have not been described to bind
each other. In contrast to the flexibility of extracellular
RGD-containing loops, the RGD sequence in APEG-1
forms a defined, rigid 310 helix. Moreover, the APEG-1
RGD motif is only involved in intra-molecular salt
bridges, while extracellular RGD motifs have been shown
to be involved in inter-molecular salt bridges [32]. Inter-
estingly, the domains Ig14 and Ig17 of twitchin [31] con-
tain the RGD motif, and several domains in the titin I-
band contain RGD or KGD motifs [33] at the same posi-
tion as in APEG-1. APEG-1 is an intracellular protein
which points to a possible role of the RGD motif not only
in extracellular but also in intracellular protein-protein
interactions. However, the way the RGD motif contributes
to the homophilic interaction of APEG-1 is obviously
quite different from the binding of RGD-containing flexi-
ble loops during cell adhesion events.
Conclusion
Protein engineering facilitated the crystallization of
APEG-1. APEG-1 forms a homodimer which is stabilized
by salt bridges. This dimerisation is not very strong and its
physiogical relevance remains to be established. To our
knowledge, the APEG-1 structure has the highest resolu-
tion of all structures of Ig(-like) domains currently present
in the Protein Data Bank.
Methods
Disorder prediction, cloning and expression
Unordered regions were assigned using algorithms availa-
ble from the DisEMBL™ package [23] and PONDR® [24].
A full-length cDNA fragment and a fragment lacking four-
teen residues at the N-terminus of APEG-1 (Gen-
Bank:AAH06346) were amplified by PCR from the clone
MPMGp800N13557 [34]. Amino acids 15 (Gly) and 16
(Ser) of APEG-1 were not included deliberately into the
truncated expression construct, but are encoded by the
BamHI restriction site that was used for cloning. For the
full-length construct, primers GAA GAT CTA AGC CCA
GTC CCA GCC AG and pQE276, sequence GGC AAC
CGA GCG TTC TGA AC were used. The truncated con-
struct was created using the primer GAA GAT CTA AGG
CAC CCC CCA CCT. The PCR products were cleaved with
BglII and NotI and cloned between the BamHI and NotI
sites of pQTEV (GenBank:AY243506). The resulting plas-
mids were introduced into E. coli SCS1 cells carrying the
pRARE plasmid [35]. The full-length construct (2–113,
PSF ID 108439) has the ID PSFEp250B082 at the RZPD
German Resource Center [36]. The truncated construct of
APEG-1 (15–113), termed ∆APEG-1, was given the PSF ID
111408 and the RZPD ID PSFEp250B117.
Fermentation and protein purification
The E. coli SCS1 clone expressing ∆APEG-1 was fermenter-
grown to an OD600 of 8 in 4 l of SB medium (12 g/l bacto-
tryptone, 24 g/l yeast extract, 0.4% (v/v) glycerol, 17 mM
KH2PO4, 72 mM K2HPO4) supplemented with 20 µg/ml
thiamine, 100 µg/ml ampicillin and 34 µg/ml chloram-
phenicol. Protein expression was induced with 1 mM iso-
propyl-β-D-thiogalactopyranoside (IPTG) for 3 h at 37°C.
Cells were pelleted by centrifugation and washed in
extraction buffer (20 mM Tris-HCl, pH8.0, 300 mM NaCl,
0.5 mM EDTA (ethylenediaminetetraacetic acid), 1 mM
PMSF (phenylmethylsulfonylfluoride), 5 mM 2-mercap-
toethanol). The cells were lysed, and cell lysates and pro-
teins were stored at 4°C. Protein purification steps were
performed at room temperature. The pellets of the pro-
tein-expressing cells were resuspended in a 4 to 6-fold vol-
ume of extraction buffer. Lysozyme was added to 0.4 mg/
ml and cells were disrupted by sonification. Cellular
debris was removed by centrifugation (55,000 × g, 45
min) and the supernatant was filtrated through cellulose
nitrate (0.45 µm). The pH of the solution was adjusted to
pH7.4 and the extract was applied to a 10-ml TALON
Superflow 16/20 column (BD Biosciences) equilibrated
with buffer (20 mM Tris-HCl, pH 7.4, 500 mM NaCl, 10
mM imidazole). The protein was eluted using buffer con-
taining 50 mM NaCl, 200 mM imidazole, 0.5 mM EDTA,
and 1 mM DTT (dithiothreitol). TEV protease (1:40) was
added to effect removal of the His6 tag (overnight, 4°C).
The protein solution was diluted 5-fold in 20 mM Tris-
HCl, pH7.4 and applied to a 4 ml-POROS 20 HQ anion-Page 5 of 8
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The flow-through of the anion-exchange chromatography
was applied to a POROS 20 S cation-exchange chromatog-
raphy column (8 ml volume), and ∆APEG-1 was again
found in the flow-through. After size-exclusion chroma-
tography (Superdex75 XK 16/60, Amersham) the protein
yield was 23.5 mg. Samples were stored in 15 mM Tris-
HCl, pH7.4, 50 mM NaCl, 0.1 mM EDTA, 2 mM DTT,
0.02% NaN3.
Biophysical experiments
Monodispersity of the sample was confirmed by dynamic
light scattering experiments (spectroscatter 201, RiNA
RNA-Network GmbH, Berlin, Germany). Thermal stabil-
ity and the midpoint of the unfolding transition were
determined by differential scanning calorimetry (capDSC,
MicroCal, LLC).
Quaternary structure analyses were done with the sedi-
mentation equilibrium technique using an analytical
ultracentrifuge XL-A (Beckman, Palo Alto CA) as
described earlier [37,38]. About 70 µL APEG-1 or ∆APEG-
1 protein dissolved in (15 mM Tris-HCl, pH 7.4, 0.1 M
NaCl, 0.1 mM EDTA, 0.2% NaN3) were centrifuged 2 h in
6-channel cells at 32,000 rpm (overspeed) followed by
26–30 h equilibrium speed at 28,000 rpm and 10°C. The
radial absorbance distributions at sedimentation equilib-
rium were recorded at three different wavelengths
between 270 and 300 nm and fitted globally to the molec-
ular mass using our program POLYMOLE [37]. In case of
a monomer-dimer equilibrium the molecular mass values
can be considered as weight average data Mw = (cm· Mm +
cd·Md)/(cm+ cd) defined by the molecular masses of mon-
omers and dimers and their partial concentrations from
which the equilibrium dissociation constant Kd was deter-
mined.
Crystallization and data collection
Crystallization trials using the vapor diffusion method
were set up by a semi-automated dispensing system [39]
in a 96-well Greiner Crystal Quick™ low-profile plate.
Crystals were obtained from droplets comprising 400 nl
of protein (57.2 mg/ml) plus 400 nl of (30% polyethylene
glycol monomethylether 2000, 200 mM (NH4)2SO4, 100
mM Na-acetate, pH 4.6) equilibrated against 75 µl of res-
ervoir solution. Crystals grew in multiple fan-like clusters
of thick plates within 7 days at 20°C. The crystals belong
to the monoclinic space group C2 with unit cell dimen-
sions of a = 81.5 Å, b = 25.5 Å, c = 42.5 Å and β = 104.6°.
One molecule in the asymmetric unit corresponds to a VM
value [40] of 1.8 Å3/Da assuming one molecule in the
asymmetric unit and a solvent content of 32%. A portion
of the crystal was extracted from the cluster and was
briefly transferred to a cryo-protectant solution consisting
of the mother liquor supplemented with 10% PEG 400.
The crystal was flash-cooled in a liquid nitrogen stream at
100 K and the beam was centered to one edge of the crys-
tal to obtain diffraction from a single crystal. Diffraction
data were collected on a MAR345 imaging plate detector
using the synchrotron source at a wavelength of 0.9184 Å
(beamline PSF-ID14.2 at BESSY, Free University, Berlin).
A dataset to 0.96-Å resolution was obtained in two sweeps
in order to optimize the high-resolution intensities and to
obtain complete low-resolution data. The measured data
were integrated, scaled and merged using the programs
DENZO and SCALEPACK [41] (Table 1).
Molecular replacement, model building and refinement
The crystal structure of ∆APEG-1 was determined by
molecular replacement using the program Auto-AMoRe
[42] implemented via the CCP4 GUI suite [43]. A homol-
ogy model was constructed using SWISS-MODEL in the
program's default settings [44] based on PDB coordinate
sets 1FHG, 1BIH and 1CS6. The derived model was used
as the starting model for molecular replacement phasing
with diffraction data in the resolution range 8.0-3.0 Å. A
clear solution for the single molecule in the asymmetric
unit was obtained as indicated by the correlation coeffi-
cient of 0.446 for the best solution and 0.317 for the sec-
ond best solution. Density improvement and removal of
model bias along with automatic model tracing was per-
formed by the free-atom refinement method in ARP/
wARP [45] using data to 1.7 Å resolution. The electron
density map allowed 97% of the model to be built auto-
matically. The model was subsequently completed manu-
Table 1: Data Collection and Refinement Statistics
Wavelength (Å) 0.9184
Resolution range (Å) 20.0 0.96
Number of measured reflections¶ 183,130 (3,132)
Unique observations¶ 46,733 (1,651)
Redundancy¶ 3.9 (1.9)
Completeness (%)¶ 89.7 (47.3)
Rmerge¶ 0.07 (0.16)
Average I/σ(I)¶ 29.9 (4.5)
Number of reflections for refinement 43,956
Number of reflections in Rfree set 2,384
R factor † 0.160
Free R factor ‡ 0.172
Overall correlation coefficient 0.957
Free correlation coefficient 0.953
r.m.s.d. bond lengths (Å) 0.015
r.m.s.d. bond angles (°) 1.78
Number of non-hydrogen atoms 765
Average B factor (Å2) 7.3
¶Statistics for the highest resolution bin (0.98 Å – 0.96 Å) are given in 
parentheses.
†R = Σ Σh||Fo(h)| - k|Fc(h)||/Σh|Fo(h)|
‡Free R factor was calculated using a 5% randomly selected subset of 
the total number of reflections.Page 6 of 8
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temperature factors to atomic resolution (0.96 Å) using
REFMAC [47]. Alternative side-chain conformations were
assigned for residues S25, S40, L54, Q58, R102, E109, and
water molecules were added into positive difference den-
sity if they were hydrogen-bonded to polar atoms. During
the final stages of the refinement, anisotropic temperature
factors were applied to the non-hydrogen atoms and
hydrogens were included as riding atoms. The final refine-
ment statistics are shown in Table 1. The relatively high R
factors are associated to the weak and incomplete diffrac-
tion data at high resolution. The final model contains 96
residues and 151 water molecules. No electron density
was visible for the terminal residues G15, S16 and E113,
and they were excluded from the model. The stereochem-
ical quality of the model was assessed using the programs
PROCHECK [48] and SFCHECK [49]. The atomic coordi-
nates for the final model and experimental structure fac-
tors are accessible under the PDB code 1U2H. Figures
were prepared using Molscript [50] and Pymol [51].
Database search for high resolution immunoglobulin 
structures
We have searched the PDB and SCOP databases for high
resolution structures of immunoglobulin domains. A list
of structures with at most 1.1 Å resolution and at least 50
amino acids length was compared to a list of structures of
the immunoglobulin superfamily obtained from SCOP
1.69 [52].
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